Mergers & Acquisitions Mergers & Acquisitions

In Hapvida-Intermédica merger review, more than 70 companies queried on impact on healthcare, hospital markets in Brazil states

By Ana Paula Candil
  • 13 Jul 2021 17:09
  • 15 Jul 2021 10:08
More than 70 market players including health insurance firms Amil, SulAmérica and Bradesco Seguros have been queried by the Brazilian competition authority about which states will be affected by Hapvida's planned merger with Notre Dame Intermédica and whether the deal would hinder “eventual expansion plans” from competitors in the markets for healthcare

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Ana Paula Candil

Senior Correspondent, Latin America

Ana Paula joined MLex in Brazil in 2014 writing about antitrust investigations and merger reviews. Prior to that, she worked for several trade publications and in TV. She lived in Washington DC, where she worked for Al Jazeera English in 2010. She studied journalism and holds a postgraduate diploma in International Business Management from the George Brown College in Toronto and a Master of Business Administration diploma in government relations from Fundação Getúlio Vargas (FGV).

Discover MLex

Stay on top of global regulatory developments

Latest News